Brought to you by:
Medtronic recalls unused Valiant Navion thoracic stent graft system
Medtronic has voluntarily issued a global recall of its Valiant Navion thoracic stent graft system and informed physicians to immediately cease use of the device until further notice. In accordance with its commitment to patient safety—and in consultation with independent…
‘Vascular surgery is an integral part of a complete healthcare system’
A new Society for Vascular Surgery (SVS) report highlights both the critical skills vascular surgeons provide to a healthcare system and the specialty’s benefit to an institution’s bottom line. “The value of the modern vascular surgeon to the healthcare system:…
New SVS online portal heralds vascular education ‘on the go’
To great excitement on the part of leaders and members, the Society for Vascular Surgery (SVS) has launched its new Education Portal, the online hub for all SVS education content. The portal links to SVS’s live education offerings, the new…
SVS PAC recaps 2020, offers goals for 2021
It is difficult to put 2020 into words. However, despite everything bad that has gone on in the U.S. and nationally, the SVS PAC was lucky to have some successes. At the beginning of 2020, the PAC was losing ground…
UPDATED: First post-virus vascular meeting with in-person element declared success
The first major conference in the vascular surgery universe to incorporate an in-person element as part of a hybrid format has been declared a success, portending what attendees might expect from the 2021 Vascular Annual Meeting (VAM) set for San…
SVS solicits comments on clinical practice guidelines covering carotid disease
The Society for Vascular Surgery (SVS) is seeking comments by Feb. 24 on proposed clinical practice guidelines for the management of extracranial cerebrovascular disease—which would update those published in the Journal of Vascular Surgery (JVS) in 2011. The SVS Document…
Surgeons discuss early efforts rolling out SVS Branding Toolkit
Two-and-a-half years back, when Kathryn E. Bowser, MD, joined her current institution as a vascular surgeon, a confluence of unfolding events led her to a realization: “A lot of people did not understand what the modern vascular surgeon actually did.”…
SVS seeks volunteers to test website navigability
The Society for Vascular Surgery (SVS) is on the lookout for volunteers to help fine-tune a planned overhaul of vascular.org, the SVS website. Testers are required to undertake 10- to 15-minute website navigation tests before Feb. 22. The effort is…
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment of patients with peripheral arterial disease (PAD). Selution SLR is a novel sirolimus-eluting balloon that provides…
Veterans study: No evidence of increased risk of death with use of PCDs out to three years
A study of more than 10,000 U.S. veterans with peripheral arterial disease (PAD) undergoing endovascular interventions in the femoropopliteal segment found that rates of two‐ and three‐year all‐cause mortality were similar among patients undergoing revascularization with a paclitaxel-coated device (PCD)…